leisure time -WSS

leisure time

author：hotspot 2025-09-30 23:40:45 - browse：4

Without question, the new federal law banning surprise billing is achieving its goal of protecting patients from enormous medical bills. But in doing so, the measure, which was initially projected to lower federal spending, appears to be raising costs elsewhere.

The Biden administration’s new progress report on the process for arbitrating disagreements between insurance companies and providers, which covers the first six months of 2023, shows that in over 80% of payment disputes, the arbiter settled on an amount that was more than the median in-network rate for that service. In other words, insurers were ordered to pay more to an out-of-network provider than they’d pay to a contracted one. Not only that, the sheer volume of disputes means the three federal agencies that run the program are devoting much more time to it than expected.

“It raises concerns for folks that envisioned the arbitration process as helping to moderate costs rather than be a tool these companies can leverage to obtain even higher payments,” said Zachary Baron, the director of Georgetown University’s Health Policy and Law Initiative.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Medicare isn't yet testing food as medicine

WSS

Anavex keeps shifting the goalposts in its clinical trials

NEJM study measures Covid brain fog, impact on IQ

In same hospitals, Black patients receive fewer opioids than white patients

Virtual repurposing can help discover new uses for existing drugs

NIH trials fail to test meaningful long Covid therapies, experts say

Study fuels hope CAR

hotspot

leisure time

focus

Medicare details structure of new drug price negotiation program

Naloxone nonprofit donates 200,000 doses after FDA approval

Medical leaders decry Supreme Court decision on affirmative action

CDC panel: People 65 and older should get a Covid spring booster shot

Jerome Adams on the need for new antivirals for Covid

Anavex keeps shifting the goalposts in its clinical trials

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Drastic changes should bring profitability, startup health insurers say

Trump demands the U.S. pay no more for drugs than other countries … again

Virtual repurposing can help discover new uses for existing drugs

knowledge

NIH trials fail to test meaningful long Covid therapies, experts say

Friends ask where James Watson's attitudes about race came from

FDA panel issues narrow recommendation for Covid vaccine booster doses

Children’s Hospital revives plan for pedestrian bridge

'Vaccine

Change Healthcare cyberattack shows risk of industry consolidation

knowledge

focus

explore

leisure time